Featured Articles
-
Overcoming Complex Patient Recruitment Challenges With Data
4/15/2025
Overcome roadblocks to recruiting patients for rare disease clinical trials with RWD and RWE, including lack of diagnosis and stringent I/E criteria, geographic dispersion, and high dropout rates.
-
Global Trial Disclosure Landscape Grows Increasingly Complex
4/15/2025
The industry is witnessing a global trend toward increased transparency and more stringent enforcement of clinical trial reporting requirements. However mechanisms and penalties differ significantly across regions and countries.
-
Faster Trial Planning and Site Selection
4/15/2025
Address the challenges of identifying the most suitable trial sites and investigators while optimizing feasibility planning, reducing screen failure rates, and improving patient retention.
-
A Dip In New Active Substance Launches Annual Review 2025 Supplement
4/15/2025
Even though new active substance (NAS) launches declined 11% in 2024, this still represented the fourth-highest total of newcomers to the pharma runway recorded and predictions remain good for 2025.
-
Life Sciences Companies Talk Past, Present, And Future At JPM
3/21/2025
The 43rd annual J.P. Morgan Healthcare Conference featured presentations from a host of large, medium, and small-cap life sciences companies that discussed past performance and future outlooks.
-
Continued Growth In Pharma R&D For 2025
3/21/2025
Explore this breakdown of the key findings in Citeline's full Pharma R&D Annual Review 2025 through easy-to-understand graphs and charts that highlight trends in the R&D pipeline.
-
Rare Disease R&D: Continued Growth Amid Challenges
3/21/2025
The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.
-
Outlook 2025: Key Trends & Insights
2/19/2025
Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.
-
Answer Your Critical Clinical Questions — Faster Than Ever
2/19/2025
Pressing clinical planning questions to ask about feasibility, investigator selection, patient enrollment, clinical trial disclosure, and more.
-
Antibody-Drug Conjugates: 'Magic Bullets' Become Reality
2/19/2025
Cancer therapy has evolved from potent chemotherapy to targeted biological therapy, including antibody-drug conjugates (ADCs). Learn more about ADCs’ makeup, mechanisms, and the development landscape.